We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+12.87%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$431M
AUM Growth
+$70.9M
Cap. Flow
+$79.1M
Cap. Flow %
18.34%
Top 10 Hldgs %
23.13%
Holding
178
New
54
Increased
29
Reduced
23
Closed
43

Top Buys

Rank Stock Value
1
XTNT icon
Xtant Medical Holdings
XTNT
+$14.7M
2
PALI icon
Palisade Bio
PALI
+$11M
3
POL.WS
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
+$10.1M
4
ECOR icon
electroCore
ECOR
+$8.6M
5
KLR
Kaleyra, Inc.
KLR
+$8.24M

Top Sells

Rank Stock Value
1
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$8.32M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
+$5.67M
3
STRO icon
Sutro Biopharma
STRO
+$5.16M
4
MBTCU
Nocturne Acquisition Corporation Unit
MBTCU
+$5M
5
IMNN icon
Imunon
IMNN
+$4.83M

Sector Composition

Rank Sector Weight
1 Healthcare 84.75%
2 Financials 3.74%
3 Technology 1.96%
4 Consumer Discretionary 0.54%
5 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CZOO
101
DELISTED
Cazoo Group Ltd
CZOO
$1.25M 0.29%
63
+13
+26% +$260K
QNGY
102
DELISTED
Quanergy Systems, Inc.
QNGY
$1.1M 0.26%
5,560
+560
+11% +$112K
ACHV icon
103
Achieve Life Sciences
ACHV
$684M
$1.1M 0.25%
+122,000
New +$1.16M
ARYD
104
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$1.07M 0.25%
100,000
– –
BLSA
105
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$1.05M 0.24%
100,000
– –
IRTC icon
106
iRhythm Holdings
IRTC
$4.09B
$1.01M 0.23%
+15,206
New +$1.2M
FRGE
107
DELISTED
Forge Global Holdings
FRGE
$998K 0.23%
6,807
– –
OMEG
108
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$995K 0.23%
100,000
– –
QELL
109
DELISTED
Qell Acquisition Corp. Class A Ordinary Shares
QELL
$995K 0.23%
100,000
– –
OPAD icon
110
Offerpad Solutions
OPAD
$21.8M
$993K 0.23%
667
– –
FMAC
111
DELISTED
FirstMark Horizon Acquisition Corp.
FMAC
$993K 0.23%
100,000
– –
COCP icon
112
Cocrystal Pharma
COCP
$14.1M
$970K 0.23%
+64,667
New +$983K
INMB icon
113
INmune Bio
INMB
$50.5M
$918K 0.21%
+52,257
New +$704K
HEPA
114
DELISTED
Hepion Pharmaceuticals
HEPA
$883K 0.2%
+446
New +$816K
GRI
115
GRI Bio
GRI
$2.71M
– –
0
– –
MITAU
116
DELISTED
Coliseum Acquisition Corp. Unit
MITAU
$840K 0.19%
+85,000
New +$841K
ONCT
117
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$818K 0.19%
8,611
-203
-2% -$24.1K
TKNO icon
118
Alpha Teknova
TKNO
$301M
$593K 0.14%
+25,000
New +$633K
CLBR.U
119
DELISTED
Colombier Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
CLBR.U
$496K 0.12%
+50,000
New +$496K
TMPO
120
DELISTED
Tempo Automation Holdings, Inc. Common Stock
TMPO
$483K 0.11%
48,530
-140,470
-74% -$1.4M
IFRX icon
121
InflaRx
IFRX
$261M
$479K 0.11%
161,206
-613,394
-79% -$2.03M
CHAQ.WS
122
DELISTED
Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
CHAQ.WS
$469K 0.11%
731,561
– –
HUMAW icon
123
Humacyte Inc Warrant
HUMAW
$1.09M
$385K 0.09%
+137,500
New +$365K
HCDIW
124
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$378K 0.09%
+600,000
New +$422K
BCTXW
125
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$377K 0.09%
209,540
-290,460
-58% -$363K
3 4
5
6 7

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
LSA
Liberty Street Advisors New York $41.4M AUM 34.47% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return

Altium Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Altium Capital Management held 178 positions worth $431M, up 20% from $360M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Altium Capital Management deployed $79.1M of net new capital in Q2 2021, opening 54 new positions and adding to 29 existing holdings. Its largest new stake was Xtant Medical Holdings: 8,292,602 shares worth $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 83% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verastem, an estimated $2.98M trimmed.

  • Altium Capital Management's largest Q2 2021 buy was Xtant Medical Holdings: 8,292,602 shares worth $13.5M.
  • Altium Capital Management added most to CTI BioPharma Corp. (DE) Common Stock in Q2 2021, an estimated $7.41M increase.
  • Altium Capital Management's biggest Q2 2021 reduction was Verastem, cutting an estimated $2.98M.
  • Altium Capital Management fully exited Biora Therapeutics, Inc. Common Stock in Q2 2021, selling an estimated $8.32M.
  • Altium Capital Management's ten largest holdings make up 23% of its $431M portfolio in Q2 2021.
  • Altium Capital Management opened 54 new positions and closed 43 in Q2 2021.
  • Altium Capital Management's portfolio value rose 20% quarter-over-quarter to $431M.

Based on Altium Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.